Work

Assessing Infection Risks with Belatacept in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analytic

Year: 2025

Type: article

Abstract: Purpose: Belatacept, a T-cell costimulation blocker, has gained attention as an alternative to calcineurin inhibitors (CNIs) in solid organ transplantation due to lower nephrotoxicity. This study evaluates the infection risk associated with belatacept in solid organ transplantation (SOT).

Source: American Journal of Transplantation

DOI: 10.1016/j.ajt.2025.07.1389

Authors: I. Tawhari, M. Alotaibi, F. Yamani, E. Hany, A. Muath, Y. Shabi

Institutions: King Khalid University, Umm al-Qura University, King Faisal Specialist Hospital & Research Centre, Armed Forces Hospital Southern Region

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,300